REFERENCES
- Nilius AM, Shen LL, Hensey-Rudloff D et al. In vitro antibacterial potency and spectrum of ABT-492, a new fluoro-quinolone. Antimicrob Agents Chemother 2003; 47: 3260–3269.
- Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, eds. Manual of Clinical Microbiology, 8th ed. Washington, DC: ASM Press. 2003.
- National Committee for Clinical Laboratory Standards. Methods for antimicrobial susceptibility testing of anaerobic bacteria; Approved Standard - Fifth ed. NCCLS document M11-A5. Wayne, Pa: National Committee for Clinical Laboratory Standards. 2001.
- Bryskier A. Anti-anaerobic activity of antibacterial agents. Exp Opin Invest Drugs 2001; 10: 239–267.
- Goldstein EJC, Citron DM, Vreni Merriam C et al. In vitro activities of ABT-492, a new fluoroquinolone, against 155 aerobic and 171 anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis. Antimicrob Agents Chemother 2003; 47: 3008–3011.
- Hedberg M, Nord CE et al. Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe. Clin Microbiol Infect 2003; 9: 475–488.